An interventional study of Induction to efficient treatment and Doubt to the efficacy of treatment in Impotence and Erectile Dysfunction, sponsored by Rio de Janeiro State University. Completed. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2009-04-17.
Sponsored by Rio de Janeiro State University · Not applicable, Interventional, and Treatment
Placebo-controlled randomized clinical trials (RCT) are the gold standard to provide applicable evidence for clinical practice. A vast number of RCTs for treatment of several disorders has shown a mean placebo effect of 30%. Erectile dysfunction (ED) is a high prevalent disease and its first-line therapy is oral phosphodiesterase type-5 inhibitor (iPDE5) (i.e., sildenafil, vardenafil and tadalafil). Although the placebo effect in iPDE5 RCT occurred at a rate as high as 50%, in the last decade, with the revolutionary discovery of effective pharmacotherapy for ED, oral iPDE5 has become one of the most common prescribed drugs for men. The objective of this study is to evaluate the influence of patients' awareness on the composition of the therapeutic drug in the outcomes of the oral treatment for ED.
683 studies on the registry are indexed under Erectile Dysfunction; 117 are open to participants now.
This study's enrollment of 123 is above the median of 72 across 542 interventional studies indexed under Erectile Dysfunction.
Browse Erectile Dysfunction studies →Rio de Janeiro State University is the lead sponsor of 62 studies on the registry; 6 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Arm 1 received an informative letter explaining that they were allocated to receive a substance for Erectile Dysfunction treatment.
Other: Induction to efficient treatment
Arm 2 (A2) was written informed that they could or could not receive an active drug for ED treatment.
Other: Doubt to the efficacy of treatment
Arm 3 (A3) was properly written informed to be using no effective drug for ED treatment.
Other: Induction to ineffective treatment
Informative letters.
Informative letters.
Informative letters
IIEF erectile function domain score
Time frame: 4 AND 8 Weeks
Quality of Erection Questionnaire (QEQ)
Time frame: 4 and 8 weeks
IIEF orgasmic function, sexual desire, intercourse satisfaction and overall satisfaction domain scores
Time frame: 4 and 8 weeks
SEAR questionnaire
Time frame: 4 and 8 weeks
EDITS questionnaire
Time frame: 4 and 8 weeks
GEAQ questionnaire
Time frame: 4 and 8 weeks
No study locations are listed for this record.
This study is completed, as verified in Apr 2009. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Rio de Janeiro State University